Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) (S.A.E) (EGX:RMDA)
Egypt · Delayed Price · Currency is EGP 5.13
+0.04 (0.79%)
At close: May 14, 2026
Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) (S.A.E) Company Description
Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) (S.A.E), together with its subsidiaries, engages in producing, marketing, selling, and storing pharmaceutical reagents for human and veterinary use.
It is also involved in producing, marketing, selling, and storing diagnostic reagents for individuals, laboratories, and hospitals; importing pharmaceutical reagents and raw materials; producing pharmaceutical reagents for human, veterinary, and diagnostic use; and producing food supplements for human use.
The company was incorporated in 1986 and is based in 6th of October City, Egypt.
Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) (S.A.E)
| Country | Egypt |
| Founded | 1986 |
| Industry | Pharmaceutical Preparations |
| CEO | Amr Morsy |
Contact Details
Address: Second Industrial Zone 6th of October City Egypt | |
| Phone | 20 2 3761 3074 |
| Website | ramedapharma.com |
Stock Details
| Ticker Symbol | RMDA |
| Exchange | Egyptian Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | EGP |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Amr Morsy | Chief Executive Officer |
| Mohamed Aboamira | Chief Financial Officer |
| Mahmoud Mustafa Salaheddine Fayek | Chief Operating Officer |
| Khaled Daader | Head of Investor Relations |